Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV

Conducting an early phase clinical trial to assess HPV Antigen Presentation Therapeutic Biological Product Mix that suggests the potential for clinical benefit of HPV patients. 20 Cervical HPV Infection Patients Inclusion Criteria: * Cervical HPV Infection Patients * Positive testing HPV by standard PCR assay * HPV infection without symptoms * No clinical signs indicative of oncology * TB negative participant is negative IGRA blood test with TB antigens Exclusion Criteria: * Pregnant * Thrombosis * Bleeding * Allergy * TB positive participant is positive IGRA blood test with TB antigens * Symptoms of HPV infection * Clinical signs suggestive of other infection * Symptoms suggestive of other infection * Clinical signs indicative of oncology * Evidence of critical illness